Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 423
interventional 285
Observational 128
Registry 10

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 103
Procedure 34
Device 31
Drug|Procedure 27
Drug|placebo 23
Drug|Other 13
Other 10
Behavioral 9
Biological 7
Dietary Supplement 7
Genetic 4
Diagnostic Test 3
Device|Drug 2
Device|Procedure 2
Other|Procedure 2
Behavioral|Device|Drug 1
Behavioral|Drug|Procedure 1
Biological|Other 1
Device|Drug|Other 1
Device|Drug|Procedure 1
Device|Other 1
Dietary Supplement|Drug 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 97
NA 28
Mexico 19
China 15
France 11
Brazil 10
Austria 7
Italy 7
Denmark 6
Korea, Republic of 5
United Kingdom 5
Canada 4
United States|Canada 4
Australia 3
Germany 3
Iran, Islamic Republic of 3
Japan 3
Taiwan 3
Egypt 2
India 2
Ireland 2
Israel 2
Portugal 2
Saudi Arabia 2
Spain 2
Thailand 2
Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Czechia|Estonia|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Netherlands|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Czechia|Estonia|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Netherlands|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Australia|Canada|Netherlands 1
Australia|Denmark 1
Australia|New Zealand 1
Austria|Czech Republic|Germany|Italy|United Kingdom 1
Bangladesh 1
Belgium|Czechia|Denmark|Germany|Greece|Italy|Macedonia, The Former Yugoslav Republic of|Netherlands|Spain|United Kingdom 1
Croatia 1
Denmark|France|Germany|Italy|Portugal|Spain|United Kingdom 1
France|Italy|Portugal|United Kingdom 1
Germany|Hungary|United Kingdom 1
Greece 1
Hong Kong 1
Italy|United States|Austria|Belgium|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Greece|Hungary|India|Japan|Lithuania|Malaysia|Mexico|Poland|Romania|Russian Federation|Saudi Arabia|Slovakia|Taiwan|Turkey|United Kingdom 1
Lebanon 1
Norway 1
Romania 1
Sweden 1
Switzerland 1
Syrian Arab Republic 1
Turkey 1
United States|Australia 1
United States|Australia|Austria|Belgium|Czechia|France|Germany|Israel|Korea, Republic of|Malaysia|Netherlands|Portugal|Spain|Sweden|Switzerland|Taiwan 1
United States|Austria|Belgium|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Greece|Hungary|India|Italy|Japan|Lithuania|Malaysia|Mexico|Romania|Russian Federation|Saudi Arabia|Slovakia|Taiwan|Turkey|United Kingdom 1
United States|Austria|Greece|Italy|Norway|Portugal|Spain|United Kingdom 1
United States|Belgium 1
United States|Belgium|Canada|France 1
United States|Belgium|Canada|France|Germany|Netherlands|United Kingdom 1
United States|Colombia|Thailand|Vietnam 1
United States|Czechia|France|Germany|Hungary|Israel|Italy|Spain|United Kingdom 1
United States|Germany|Hungary|Japan|Puerto Rico|United Kingdom 1
United States|Italy|Netherlands|Poland|Sweden|United Kingdom 1
United States|Puerto Rico 1
United States|Puerto Rico|Slovakia|Spain|United Kingdom 1
United States|United Arab Emirates 1

Sites per Study

Site_count Study_Count
1 195
2 21
3 12
4 7
5 2
6 2
7 6
8 1
9 3
11 2
12 2
13 1
14 1
15 3
16 2
17 1
18 1
21 1
23 1
24 2
34 1
37 1
38 1
43 1
45 1
48 1
50 2
53 1
56 1
62 1
67 1
74 1
76 1
85 1
86 1
89 1
123 1
127 1

Phase

Phase Study_Count
N/A 104
Phase 2 53
Phase 3 44
Phase 1 28
Phase 4 24
Phase 1/Phase 2 16
Phase 2/Phase 3 13
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 58
2 147
3 34
4 10
5 2
6 2
8 1
9 1
12 1
NA 29

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 50 6.0000 3.00000 3.0000 6.00000 20.0000 14.0000 15.0000
1st Qu. 75 36.5000 9.00000 9.5000 25.50000 30.0000 90.0000 20.0000
Median 100 90.0000 12.00000 19.0000 46.00000 139.0000 233.5000 40.0000
Mean 250 302.6699 29.82143 22.4375 76.32692 315.1667 685.0263 134.2609
3rd Qu. 350 257.0000 35.50000 31.2500 105.50000 308.2500 659.5000 75.5000
Max. 600 7200.0000 165.00000 56.0000 315.00000 1777.0000 5238.0000 1060.0000

Trial Group Type

group_type Group_Count
Experimental 288
Active Comparator 138
Placebo Comparator 49
NA 29
Other 26
No Intervention 25
Sham Comparator 19

Intervention Model

intervention_model Study_Count
Parallel Assignment 171
Single Group Assignment 80
NA 12
Crossover Assignment 10
Sequential Assignment 7
Factorial Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 195
Prevention 25
Diagnostic 21
Other 10
Basic Science 8
Health Services Research 7
Screening 7
Supportive Care 6
NA 4
Device Feasibility 2

Observational Studies

Studies by Country

Country Study_Count
United States 57
NA 11
China 8
Portugal 6
France 5
Taiwan 4
United Kingdom 4
Korea, Republic of 3
Turkey 3
Brazil 2
Italy 2
Japan 2
Mexico 2
Switzerland 2
Austria 1
Belgium 1
Bolivia 1
Canada 1
Canada|United Kingdom 1
Denmark 1
Germany 1
India 1
India|Portugal 1
Saudi Arabia 1
Sweden 1
United States|Argentina 1
United States|Australia|France|Germany|Netherlands|Poland|Spain|United Kingdom 1
United States|Canada 1
United States|Canada|Denmark|Germany|Netherlands|Switzerland|United Kingdom 1
United States|France|Germany|Netherlands 1
United States|Italy|Netherlands|Poland|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 103
2 7
3 5
4 3
5 1
7 2
8 1
9 1
12 1
16 1
48 1
59 1
62 1

Enrollment Metrics

Measure Observational
Min 2.0000
1st Qu 60.0000
Median 149.0000
Mean 576.7812
3rd Qu 416.7500
Max 19199.0000

Observation Model

observational_model Study_Count
Cohort 44
Case-Only 21
Case-Control 20
NA 17
Case Control 14
Other 7
Ecologic or Community 2
Case-Crossover 1
Defined Population 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 75
Cross-Sectional 21
Retrospective 15
NA 11
Other 5
Cross-Sectional, Prospective 1

Registries

Studies by Country

Country Study_Count
China 3
United States 2
Denmark 1
Mexico 1
NA 1
Portugal 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 9
2 1

Enrollment Metrics

Measure Registries
Min 30.0
1st Qu 91.5
Median 241.0
Mean 52428.2
3rd Qu 2125.0
Max 500000.0

Registry Model

observational_model Study_Count
Cohort 7
Case Control 1
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 10

Follow-up

target_duration Study_Count
20 Years 2
1 Day 1
1 Year 1
10 Years 1
12 Months 1
16 Years 1
3 Years 1
4 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04289571 Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease https://ClinicalTrials.gov/show/NCT04289571 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT02376868 Maestro Agreement and Precision Study II https://ClinicalTrials.gov/show/NCT02376868 Completed Topcon Medical Systems, Inc. 2015-09-30
NCT04101721 Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT04101721 Recruiting Regeneron Pharmaceuticals 2022-04-01
NCT03859245 Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention https://ClinicalTrials.gov/show/NCT03859245 Recruiting Bristlecone Health, Inc. 2020-09-30
NCT03824782 The Effect of Eyemasks on Neonatal Stress Following Dilated Retinal Examination https://ClinicalTrials.gov/show/NCT03824782 Completed Sunnybrook Health Sciences Centre 2017-06-30
NCT03343730 RetinaVue Diabetic Screening https://ClinicalTrials.gov/show/NCT03343730 Recruiting Bassett Healthcare 2018-10-01
NCT03274596 Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial. https://ClinicalTrials.gov/show/NCT03274596 Completed Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 2015-10-01
NCT03242031 Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03242031 Recruiting Centre Hospitalier Universitaire Dijon 2021-03-31
NCT03238963 A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. https://ClinicalTrials.gov/show/NCT03238963 Completed Boehringer Ingelheim 2020-02-14
NCT03201588 Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM) https://ClinicalTrials.gov/show/NCT03201588 Completed Göteborg University 2019-11-15
NCT03197870 The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) https://ClinicalTrials.gov/show/NCT03197870 Completed Aerpio Therapeutics 2019-01-09
NCT03161652 Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03161652 Recruiting Universidad Nacional Autonoma de Mexico 2022-05-31
NCT03154723 Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants https://ClinicalTrials.gov/show/NCT03154723 Completed Zhengzhou Children’s Hospital, China 2017-12-31
NCT03150654 The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes https://ClinicalTrials.gov/show/NCT03150654 Completed Afyon Kocatepe University Hospital 2016-06-08
NCT03148132 VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP https://ClinicalTrials.gov/show/NCT03148132 Completed Universidad Autonoma de San Luis Potosí 2018-08-30
NCT03113006 The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) https://ClinicalTrials.gov/show/NCT03113006 Completed Odense University Hospital 2019-08-27
NCT03085784 Intravitreal Aflibercept Injection for Radiation Retinopathy Trial https://ClinicalTrials.gov/show/NCT03085784 Recruiting Greater Houston Retina Research 2021-10-31
NCT03065881 RETeval All Comers Trial (REACT) https://ClinicalTrials.gov/show/NCT03065881 Active, not recruiting LKC Technologies, Inc. 2020-12-31
NCT02995629 Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation https://ClinicalTrials.gov/show/NCT02995629 Completed Wills Eye 2016-10-31
NCT02911311 Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02911311 Enrolling by invitation Sun Yat-sen University 2019-12-31
NCT02879422 Genetic Markers and Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02879422 Recruiting CHU de Reims 2020-04-16
NCT02874313 CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea https://ClinicalTrials.gov/show/NCT02874313 Active, not recruiting Hospital Universitario La Paz 2020-10-31
NCT02866734 Diabetic Retinopathy Screening in Private Practice https://ClinicalTrials.gov/show/NCT02866734 Completed The University of Hong Kong 2017-12-13
NCT02863354 Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02863354 Active, not recruiting Greater Houston Retina Research 2019-07-31
NCT02858076 Anti-VEGF vs. Prompt Vitrectomy for VH From PDR https://ClinicalTrials.gov/show/NCT02858076 Completed Jaeb Center for Health Research 2020-01-31
NCT02857491 Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02857491 Completed Sun Yat-sen University 2017-09-30
NCT02834663 Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02834663 Completed Wonkwang University Hospital 2019-02-28
NCT02826655 Adaptive Optics for Ophthalmic Technologies https://ClinicalTrials.gov/show/NCT02826655 Recruiting Duke University 2021-06-30
NCT02820662 Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants https://ClinicalTrials.gov/show/NCT02820662 Completed Centre Hospitalier Universitaire Dijon 2018-05-31
NCT02816710 Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02816710 Completed Ruijin Hospital 2017-09-30
NCT02816073 Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02816073 Completed United Christian Hospital 2013-11-30
NCT02806830 Ocular Discomfort Assessment After Intravitreal Injections https://ClinicalTrials.gov/show/NCT02806830 Completed Centre Hospitalier Intercommunal Creteil 2017-01-31
NCT02780544 Infant-parent Skin-to-skin Contact During Screening for Retinopathy https://ClinicalTrials.gov/show/NCT02780544 Completed St. Olavs Hospital 2016-06-30
NCT02760472 A Fatty Acids Study in Preventing Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02760472 Completed Queen Silvia Children’s Hospital, Gothenburg, Sweden 2015-09-30
NCT02753400 Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02753400 Completed Kubota Vision Inc. 2017-11-30
NCT02718326 Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) https://ClinicalTrials.gov/show/NCT02718326 Completed Regeneron Pharmaceuticals 2018-08-06
NCT04424290 HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia https://ClinicalTrials.gov/show/NCT04424290 Recruiting Boehringer Ingelheim 2022-05-18
NCT02705274 PRP vs Bevacizumab for PDR Treatment https://ClinicalTrials.gov/show/NCT02705274 Completed Marashi Eye Clinic 2017-04-30
NCT02688309 Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases https://ClinicalTrials.gov/show/NCT02688309 Recruiting Johns Hopkins University 2021-07-31
NCT02683317 Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02683317 Completed Coordinación de Investigación en Salud, Mexico 2017-10-31
NCT02681809 A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR https://ClinicalTrials.gov/show/NCT02681809 Completed Oxurion 2019-11-18
NCT02671864 Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy https://ClinicalTrials.gov/show/NCT02671864 Recruiting Assistance Publique - Hôpitaux de Paris 2022-04-11
NCT02646670 Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02646670 Completed Instituto de Olhos de Goiania 2015-10-31
NCT02645383 PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System https://ClinicalTrials.gov/show/NCT02645383 Completed Kocatepe University 2014-07-31
NCT02640664 Rainbow Extension Study https://ClinicalTrials.gov/show/NCT02640664 Active, not recruiting Novartis 2022-10-30
NCT02634333 Anti-VEGF Treatment for Prevention of PDR/DME https://ClinicalTrials.gov/show/NCT02634333 Active, not recruiting Jaeb Center for Health Research 2020-05-31
NCT02621580 Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT02621580 Completed Lawson Health Research Institute 2017-08-31
NCT02620644 Retinal Ganglion Cell Complex Changes by Optical Coherence Tomography in Diabetic Patients Without Retinopathy https://ClinicalTrials.gov/show/NCT02620644 Completed Cairo University 2014-12-31
NCT02590094 Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy https://ClinicalTrials.gov/show/NCT02590094 Recruiting Panhandle Eye Group, LLP 2021-10-31
NCT02587741 Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens https://ClinicalTrials.gov/show/NCT02587741 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2023-07-31
NCT02582164 Long-Working Distance OCT for Children https://ClinicalTrials.gov/show/NCT02582164 Completed Duke University 2018-07-01
NCT04120077 Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy https://ClinicalTrials.gov/show/NCT04120077 Recruiting ZeaVision, LLC 2020-11-01
NCT04117022 Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG https://ClinicalTrials.gov/show/NCT04117022 Recruiting ZeaVision, LLC 2020-12-01
NCT03011541 Stem Cell Ophthalmology Treatment Study II https://ClinicalTrials.gov/show/NCT03011541 Recruiting MD Stem Cells 2022-01-31
NCT02559180 Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab https://ClinicalTrials.gov/show/NCT02559180 Recruiting The Cleveland Clinic 2020-11-30
NCT02543229 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentisâ„¢ in Patients With Wet AMD https://ClinicalTrials.gov/show/NCT02543229 Completed Opthea Limited 2017-02-07
NCT02510885 SD-OCT Angiography https://ClinicalTrials.gov/show/NCT02510885 Recruiting Duke University 2020-05-31
NCT02486484 Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection https://ClinicalTrials.gov/show/NCT02486484 Recruiting Rafic Hariri University Hospital 2019-05-31
NCT02486042 Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02486042 Recruiting University of California, San Diego 2019-12-31
NCT02475109 Study of Topical Ocular PAN-90806 in PDR https://ClinicalTrials.gov/show/NCT02475109 Completed PanOptica, Inc. 2016-05-31
NCT02447185 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT02447185 Recruiting The First People’s Hospital of Xuzhou 2020-12-31
NCT02435862 A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02435862 Completed Allegro Ophthalmics, LLC 2017-08-10
NCT02432547 Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) https://ClinicalTrials.gov/show/NCT02432547 Active, not recruiting University of Sydney 2021-01-31
NCT02390531 Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02390531 Active, not recruiting Jaeb Center for Health Research 2019-06-04
NCT02375971 RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02375971 Completed Novartis 2017-12-14
NCT02315170 Assessment of Novel Intraocular Injection Guide https://ClinicalTrials.gov/show/NCT02315170 Completed Maturi, Raj K., M.D., P.C. 2015-01-31
NCT02277119 Clinical Study of the Optic Disc Parameters https://ClinicalTrials.gov/show/NCT02277119 Completed Topcon Medical Systems, Inc. 2015-01-31
NCT02222610 Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. https://ClinicalTrials.gov/show/NCT02222610 Completed Greater Houston Retina Research 2019-02-28
NCT02207712 Noctura400 Treatment for Diabetic Retinopathy (CANDLE) https://ClinicalTrials.gov/show/NCT02207712 Active, not recruiting PolyPhotonix Medical 2020-07-31
NCT02164604 Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease https://ClinicalTrials.gov/show/NCT02164604 Completed Kantonsspital Aarau 2013-10-31
NCT02157350 The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT https://ClinicalTrials.gov/show/NCT02157350 Completed Odense University Hospital 2017-09-30
NCT02157077 Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration https://ClinicalTrials.gov/show/NCT02157077 Completed Centre Hospitalier Intercommunal Creteil 2015-12-31
NCT02151695 Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT02151695 Completed Poitiers University Hospital 2018-10-31
NCT02134457 Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02134457 Completed University Hospital Freiburg 2017-01-31
NCT02121340 Collaborative Care for Depression and Diabetic Retinopathy in African Americans https://ClinicalTrials.gov/show/NCT02121340 Completed Thomas Jefferson University 2018-12-31
NCT02102711 Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g https://ClinicalTrials.gov/show/NCT02102711 Completed IRCCS Policlinico S. Matteo 2015-04-30
NCT02099981 Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients https://ClinicalTrials.gov/show/NCT02099981 Completed University of Minnesota 2017-12-31
NCT02085681 Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases https://ClinicalTrials.gov/show/NCT02085681 Completed Aravind Eye Care System 2015-01-31
NCT02062034 Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02062034 Completed University of Guadalajara 2013-11-30
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01298076 Completed University of Sydney 2014-09-30
NCT01295775 Diabetic Retinopathy Sulodexide Study https://ClinicalTrials.gov/show/NCT01295775 Completed Ajou University School of Medicine 2011-04-30
NCT01281098 Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. https://ClinicalTrials.gov/show/NCT01281098 Completed Association for Innovation and Biomedical Research on Light and Image 2012-10-31
NCT01280929 Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01280929 Completed Association for Innovation and Biomedical Research on Light and Image 2013-12-31
NCT01270542 Avastin for PDR (Proliferative Diabetic Retinopathy) https://ClinicalTrials.gov/show/NCT01270542 Completed University of Southern California 2011-07-31
NCT02040441 Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria https://ClinicalTrials.gov/show/NCT02040441 Completed Steno Diabetes Center Copenhagen 2018-11-30
NCT02036632 Eye Patch Therapy for Central Serous Retinopathy (CSR) https://ClinicalTrials.gov/show/NCT02036632 Completed Washington University School of Medicine 2015-01-31
NCT04005352 Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) https://ClinicalTrials.gov/show/NCT04005352 Recruiting Novartis 2022-01-31
NCT02014454 Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature https://ClinicalTrials.gov/show/NCT02014454 Completed Azienda Ospedaliero, Universitaria Meyer 2014-08-31
NCT01988246 Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01988246 Completed The Cleveland Clinic 2018-04-25
NCT01976923 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01976923 Completed King Khaled Eye Specialist Hospital 2018-07-31
NCT01955135 Anesthesia for Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01955135 Completed TC Erciyes University 2012-12-31
NCT01950663 RETeval Study for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01950663 Completed Inoveon Corporation 2014-04-30
NCT01941329 Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT01941329 Completed Association for Innovation and Biomedical Research on Light and Image 2016-04-30
NCT01927315 Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes https://ClinicalTrials.gov/show/NCT01927315 Completed University of Padova 2019-10-31
NCT01920867 Stem Cell Ophthalmology Treatment Study https://ClinicalTrials.gov/show/NCT01920867 Enrolling by invitation MD Stem Cells 2020-07-31
NCT01875783 OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits https://ClinicalTrials.gov/show/NCT01875783 Completed Joslin Diabetes Center 2015-05-14
NCT01875510 The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities https://ClinicalTrials.gov/show/NCT01875510 Completed Dr. Sami Ulus Children’s Hospital 2013-09-30
NCT01872611 Nepafenac Once Daily for Macular Edema - Study 2 https://ClinicalTrials.gov/show/NCT01872611 Completed Alcon Research 2015-05-31
NCT01869933 Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X https://ClinicalTrials.gov/show/NCT01869933 Completed OcuCure Therapeutics, Inc. 2013-06-30
NCT01854593 Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01854593 Completed Nihon University 2013-08-31
NCT01837121 a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China https://ClinicalTrials.gov/show/NCT01837121 Completed Sun Yat-sen University 2017-06-30
NCT01813773 Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study https://ClinicalTrials.gov/show/NCT01813773 Completed Ophthalmic Consultants of Long Island 2016-04-30
NCT01805297 Aflibercept Injection for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01805297 Completed University of Oklahoma 2014-02-28
NCT01787669 Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01787669 Completed University of Sydney 2017-01-31
NCT01769183 Squalamine for the Treatment in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01769183 Completed Elman Retina Group 2014-08-31
NCT01758757 Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01758757 Completed Kyorin University 2011-01-31
NCT01753648 Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy https://ClinicalTrials.gov/show/NCT01753648 Recruiting Medical University of Vienna 2020-09-30
NCT01746563 Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01746563 Completed University of Sao Paulo 2012-08-31
NCT01743781 Uptake of Comprehensive Eye Examination Trial https://ClinicalTrials.gov/show/NCT01743781 Completed Sun Yat-sen University 2013-09-30
NCT01736059 Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy https://ClinicalTrials.gov/show/NCT01736059 Enrolling by invitation University of California, Davis 2022-01-31
NCT01726075 Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01726075 Completed BCN Peptides 2015-11-30
NCT01724554 Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion https://ClinicalTrials.gov/show/NCT01724554 Completed Ophthalmic Consultants of Boston 2014-10-31
NCT01724385 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01724385 Completed Khon Kaen University 2012-12-31
NCT01694212 Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01694212 Completed Eye Clinic Medic Zuljan Jukic 2016-10-31
NCT01660620 Topical Betaxolol for the Prevention of Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01660620 Completed Smith-Kettlewell Eye Research Institute 2011-11-30
NCT01646047 Diabetes Visual Function Supplement Study https://ClinicalTrials.gov/show/NCT01646047 Completed ZeaVision, LLC 2014-08-31
NCT01628289 The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong https://ClinicalTrials.gov/show/NCT01628289 Completed The University of Hong Kong 2009-08-31
NCT01594281 Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) https://ClinicalTrials.gov/show/NCT01594281 Completed Novartis 2016-11-30
NCT01579760 Intravitreal Aflibercept Injection for Radiation Retinopathy https://ClinicalTrials.gov/show/NCT01579760 Completed Washington University School of Medicine 2019-01-31
NCT01571232 Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01571232 Completed Retina Macula Institute 2014-02-28
NCT01535495 Propranolol for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01535495 Completed University of Wisconsin, Madison 2015-12-31
NCT01518842 Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy https://ClinicalTrials.gov/show/NCT01518842 Active, not recruiting University of Sao Paulo 2018-10-31
NCT01489189 Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01489189 Completed Jaeb Center for Health Research 2015-01-31
NCT01482195 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations https://ClinicalTrials.gov/show/NCT01482195 Recruiting King Khaled Eye Specialist Hospital 2014-08-31
NCT01468337 Topical Interferon Gamma-1b for Central Serous Chorioretinopathy https://ClinicalTrials.gov/show/NCT01468337 Completed National Institutes of Health Clinical Center (CC) 2013-11-30
NCT01404247 Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates https://ClinicalTrials.gov/show/NCT01404247 Completed Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 2015-12-31
NCT01399515 Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa https://ClinicalTrials.gov/show/NCT01399515 Completed Seoul National University Hospital 2013-08-31
NCT01383772 Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility https://ClinicalTrials.gov/show/NCT01383772 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-08-31
NCT01373476 Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01373476 Completed Chengdu University of Traditional Chinese Medicine 2013-03-31
NCT01364129 The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01364129 Completed Legacy Health System 2011-12-31
NCT01334879 High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy https://ClinicalTrials.gov/show/NCT01334879 Completed The New York Eye Cancer Center 2012-11-30
NCT01323348 Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control https://ClinicalTrials.gov/show/NCT01323348 Completed Jaeb Center for Health Research 2014-07-31
NCT01320345 The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. https://ClinicalTrials.gov/show/NCT01320345 Recruiting University of Sydney 2022-01-31
NCT02617966 Rod and Cone Mediated Function in Retinal Disease https://ClinicalTrials.gov/show/NCT02617966 Recruiting National Institutes of Health Clinical Center (CC) 2024-12-30
NCT04418427 ADVM-022 Intravitreal Gene Therapy for DME https://ClinicalTrials.gov/show/NCT04418427 Recruiting Adverum Biotechnologies, Inc. 2021-05-31
NCT04408807 Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided https://ClinicalTrials.gov/show/NCT04408807 Completed Aristotle University Of Thessaloniki 2020-02-04
NCT04380077 Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics https://ClinicalTrials.gov/show/NCT04380077 Recruiting Rush Eye Associates 2024-06-01
NCT04380064 Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04380064 Recruiting Rush Eye Associates 2024-06-01
NCT04285151 Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes https://ClinicalTrials.gov/show/NCT04285151 Completed Tanta University 2020-01-31
NCT04265261 A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04265261 Recruiting Hoffmann-La Roche 2022-02-09
NCT04255732 Comparison of Wide-field Retinal Imaging https://ClinicalTrials.gov/show/NCT04255732 Recruiting Vienna Institute for Research in Ocular Surgery 2020-10-31
NCT04246866 First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration https://ClinicalTrials.gov/show/NCT04246866 Recruiting Gemini Therapeutics, Inc. 2020-05-31
NCT04222387 Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines https://ClinicalTrials.gov/show/NCT04222387 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-12-31
NCT04191954 Fasudil Eye Drop in Retinopathy Of Prematurity(ROP) https://ClinicalTrials.gov/show/NCT04191954 Recruiting Shahid Beheshti University of Medical Sciences 2019-11-01
NCT04187443 MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema https://ClinicalTrials.gov/show/NCT04187443 Recruiting MingSight Pharmaceuticals Pty Limited 2021-08-18
NCT04130841 Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery https://ClinicalTrials.gov/show/NCT04130841 Recruiting Seoul National University Hospital 2020-09-29
NCT04123626 A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene https://ClinicalTrials.gov/show/NCT04123626 Recruiting ProQR Therapeutics 2021-10-07
NCT04120636 Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120636 Recruiting Targeted Therapy Technologies, LLC 2020-10-30
NCT04120311 Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120311 Recruiting Targeted Therapy Technologies, LLC 2020-08-25
NCT04103671 Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR https://ClinicalTrials.gov/show/NCT04103671 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2021-12-31
NCT04068831 Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT04068831 Recruiting Memorial Sloan Kettering Cancer Center 2022-08-31
NCT04038125 Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME https://ClinicalTrials.gov/show/NCT04038125 Recruiting Retina Macula Specialists of Miami, LLC 2020-08-31
NCT04015180 Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 https://ClinicalTrials.gov/show/NCT04015180 Recruiting Bayer 2025-05-15
NCT04009980 Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus. https://ClinicalTrials.gov/show/NCT04009980 Completed Fondazione G.B. Bietti, IRCCS 2018-10-31
NCT04008771 Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases https://ClinicalTrials.gov/show/NCT04008771 Completed 2C Tech Corp 2014-12-19
NCT04004208 Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy https://ClinicalTrials.gov/show/NCT04004208 Recruiting Bayer 2021-01-15
NCT03970161 Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03970161 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2021-06-01
NCT03962296 A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® https://ClinicalTrials.gov/show/NCT03962296 Completed Hanyang University 2015-01-26
NCT03954626 Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD https://ClinicalTrials.gov/show/NCT03954626 Completed Novartis 2019-07-09
NCT03913143 A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) https://ClinicalTrials.gov/show/NCT03913143 Recruiting ProQR Therapeutics 2020-12-31
NCT03913130 Extension Study to Study PQ-110-001 (NCT03140969) https://ClinicalTrials.gov/show/NCT03913130 Active, not recruiting ProQR Therapeutics 2021-03-31
NCT03904056 ETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDR https://ClinicalTrials.gov/show/NCT03904056 Completed São Paulo State University 2017-07-01
NCT03902925 Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia https://ClinicalTrials.gov/show/NCT03902925 Completed University of Sao Paulo 2019-08-31
NCT03901898 Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance https://ClinicalTrials.gov/show/NCT03901898 Active, not recruiting University College Cork 2020-06-30
NCT00837252 Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy https://ClinicalTrials.gov/show/NCT00837252 Completed National Institutes of Health Clinical Center (CC) 2010-04-30
NCT03872479 Single Ascending Dose Study in Participants With LCA10 https://ClinicalTrials.gov/show/NCT03872479 Recruiting Allergan 2024-03-22
NCT03868462 Optos P200TE Agreement and Precision Study https://ClinicalTrials.gov/show/NCT03868462 Completed Optos, PLC 2019-09-16
NCT03863535 PRP vs PRP+IVC for Severe nPDR https://ClinicalTrials.gov/show/NCT03863535 Recruiting Ruijin Hospital 2021-01-01
NCT03780257 Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene https://ClinicalTrials.gov/show/NCT03780257 Recruiting ProQR Therapeutics 2021-12-31
NCT03765112 Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT https://ClinicalTrials.gov/show/NCT03765112 Recruiting University of British Columbia 2019-12-31
NCT03712670 Nutraceutical Support With Omega-3 https://ClinicalTrials.gov/show/NCT03712670 Completed Università degli Studi di Brescia 2016-12-31
NCT03702374 Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03702374 Recruiting University of Guadalajara 2021-01-31
NCT03680794 Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies https://ClinicalTrials.gov/show/NCT03680794 Recruiting CHU de Reims 2021-12-01
NCT03672656 Pattern Laser Versus Conventional Laser in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03672656 Completed University Hospital Ostrava 2013-12-31
NCT03660384 Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy https://ClinicalTrials.gov/show/NCT03660384 Recruiting Rush Eye Associates 2020-09-04
NCT03660371 Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging https://ClinicalTrials.gov/show/NCT03660371 Recruiting Rush Eye Associates 2020-09-04
NCT03650621 Magnetic Non-Invasive Acupuncture For Infant Comfort A Pilot Study in Preterm Infants Requiring Eye-exam for Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT03650621 Active, not recruiting University of Alberta 2019-09-30
NCT03531294 Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement https://ClinicalTrials.gov/show/NCT03531294 Active, not recruiting Greater Houston Retina Research 2021-04-30
NCT03505567 Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 https://ClinicalTrials.gov/show/NCT03505567 Completed Kowa Research Institute, Inc. 2018-09-01
NCT03478306 Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm https://ClinicalTrials.gov/show/NCT03478306 Recruiting Glostrup University Hospital, Copenhagen 2020-10-01
NCT03475173 New Non-invasive Modalities for Assessing Retinal Structure and Function https://ClinicalTrials.gov/show/NCT03475173 Recruiting University of Iowa 2020-01-01
NCT03439345 Lowering Events in Non-proliferative Retinopathy in Scotland https://ClinicalTrials.gov/show/NCT03439345 Recruiting University of Oxford 2023-08-31
NCT03426540 Intravitreal Conbercept After Vitrectomy https://ClinicalTrials.gov/show/NCT03426540 Completed Tianjin Medical University Eye Hospital 2018-03-30
NCT03422965 Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03422965 Recruiting Hospital Clinic of Barcelona 2019-05-08
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment https://ClinicalTrials.gov/show/NCT01257815 Completed Novartis 2013-04-30
NCT01255293 Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments https://ClinicalTrials.gov/show/NCT01255293 Completed Mid Atlantic Retina 2012-10-31
NCT01238471 Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study https://ClinicalTrials.gov/show/NCT01238471 Completed Rambam Health Care Campus 2012-05-31
NCT01227993 Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy https://ClinicalTrials.gov/show/NCT01227993 Completed National Institutes of Health Clinical Center (CC) 2012-12-31
NCT01225653 Topical Application of Latanoprost in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01225653 Completed University of Aarhus 2014-12-31
NCT01205035 High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia https://ClinicalTrials.gov/show/NCT01205035 Completed Eye Center of Northern Colorado, P.C. 2012-10-31
NCT01203436 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01203436 Completed NICHD Neonatal Research Network 1999-03-31
NCT01201161 Ranibizumab for Diabetic Traction Retinal Detachment https://ClinicalTrials.gov/show/NCT01201161 Completed University of Sao Paulo 2010-01-31
NCT01115257 Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01115257 Completed Universita degli Studi di Catania 2006-10-31
NCT01102946 Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01102946 Completed University of Sao Paulo 2011-02-28
NCT01100307 A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01100307 Completed Pfizer 2012-08-31
NCT01096784 IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01096784 Completed Shire 2016-03-01
NCT01086631 Rituximab for Autoimmune Retinopathy https://ClinicalTrials.gov/show/NCT01086631 Completed National Institutes of Health Clinical Center (CC) NA
NCT01079715 Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01079715 Completed Azienda Ospedaliero, Universitaria Meyer 2012-10-31
NCT01069341 Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery https://ClinicalTrials.gov/show/NCT01069341 Completed Bhagat, Neelakshi, M.D., M.P.H. 2011-12-31
NCT01054027 Study on Effective Mydriasis in Premature Infants https://ClinicalTrials.gov/show/NCT01054027 Completed Georgetown University 2007-11-30
NCT01041690 Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease https://ClinicalTrials.gov/show/NCT01041690 Completed Cairo University 2008-06-30
NCT01025934 Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01025934 Completed University of Campania “Luigi Vanvitelli” NA
NCT01024803 Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients https://ClinicalTrials.gov/show/NCT01024803 Completed Retina Implant AG 2017-04-30
NCT01016873 INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD https://ClinicalTrials.gov/show/NCT01016873 Completed Oraya Therapeutics, Inc. 2012-05-31
NCT00996437 Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) https://ClinicalTrials.gov/show/NCT00996437 Completed Jaeb Center for Health Research 2012-02-29
NCT00970723 High Blood Pressure and Sleep Apnea in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00970723 Completed Assistance Publique - Hôpitaux de Paris 2014-01-31
NCT00921544 Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening https://ClinicalTrials.gov/show/NCT00921544 Completed Coombe Women and Infants University Hospital 2009-03-31
NCT00917553 Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00917553 Completed Milton S. Hershey Medical Center 2012-07-31
NCT00907114 Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00907114 Completed Hospital Juarez de Mexico 2015-03-31
NCT00904592 A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00904592 Completed Chengdu University of Traditional Chinese Medicine 2010-10-31
NCT00900887 Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema https://ClinicalTrials.gov/show/NCT00900887 Completed Hospital Juarez de Mexico 2015-03-31
NCT00821340 Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations https://ClinicalTrials.gov/show/NCT00821340 Completed Hadassah Medical Organization 2016-06-29
NCT04071977 Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT04071977 Recruiting University of Guadalajara 2021-01-31
NCT02504944 Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) https://ClinicalTrials.gov/show/NCT02504944 Completed Azienda Ospedaliero, Universitaria Meyer 2018-08-31
NCT00812760 Effect of Levodopa on Human Multifocal Electroretinogram https://ClinicalTrials.gov/show/NCT00812760 Completed Medical University of Vienna 2003-10-31
NCT01853072 Nepafenac Once Daily for Macular Edema - Study 1 https://ClinicalTrials.gov/show/NCT01853072 Completed Alcon Research 2015-05-31
NCT00806169 Combined Triple Therapy in Diabetic Retinopathy (DRP) https://ClinicalTrials.gov/show/NCT00806169 Completed Johann Wolfgang Goethe University Hospital 2008-10-31
NCT03846193 First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD https://ClinicalTrials.gov/show/NCT03846193 Recruiting Gyroscope Therapeutics 2021-06-30
NCT00804921 Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab https://ClinicalTrials.gov/show/NCT00804921 Completed University of Sao Paulo NA
NCT00804102 Transcorneal Electrical Stimulation Therapy for Retinal Disease https://ClinicalTrials.gov/show/NCT00804102 Completed Okuvision GmbH 2011-04-30
NCT00802269 Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT00802269 Completed Asociación para Evitar la Ceguera en México 2008-11-30
NCT02521116 Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap https://ClinicalTrials.gov/show/NCT02521116 Completed Medical University of Vienna 2017-01-03
NCT01920984 Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01920984 Completed National Taiwan University Hospital 2006-12-31
NCT00782717 A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT00782717 Completed Alcon Research 2010-07-31
NCT00776763 Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab https://ClinicalTrials.gov/show/NCT00776763 Completed Ophthalmological Association Edelweiss 2009-10-31
NCT00750399 Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma https://ClinicalTrials.gov/show/NCT00750399 Completed The New York Eye Cancer Center 2011-09-30
NCT00745498 Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00745498 Completed Seoul National University Bundang Hospital 2010-10-31
NCT00711490 Sirolimus to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00711490 Completed National Institutes of Health Clinical Center (CC) 2011-01-31
NCT00690768 Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) https://ClinicalTrials.gov/show/NCT00690768 Completed University of Sao Paulo 2008-05-31
NCT00682240 Morphological and Functional Retinal Changes Following Retinal Photocoagulation https://ClinicalTrials.gov/show/NCT00682240 Completed Medical University of Vienna 2014-02-28
NCT00665106 Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00665106 Completed Santen SAS 2011-09-30
NCT00656435 Bevacizumab and Long Acting Gas in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00656435 Completed National Taiwan University Hospital 2007-08-31
NCT00648687 Pain Response During Examination for Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT00648687 Completed National Bioethics Commission of Brazil 2010-06-30
NCT00623220 Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant https://ClinicalTrials.gov/show/NCT00623220 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2010-04-30
NCT00622726 Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT00622726 Active, not recruiting The University of Texas Health Science Center, Houston 2010-08-31
NCT00619034 Pharmacological Intervention in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00619034 Completed University of Aarhus 2010-12-31
NCT00604383 Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study https://ClinicalTrials.gov/show/NCT00604383 Completed Chromaderm, Inc. 2005-06-30
NCT00600262 Intravitreal Bevacizumab for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00600262 Completed Asociación para Evitar la Ceguera en México NA
NCT00600236 HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population https://ClinicalTrials.gov/show/NCT00600236 Completed Asociación para Evitar la Ceguera en México 2008-01-31
NCT00596297 Preoperative Bevacizumab for Vitreous Hemorrhage https://ClinicalTrials.gov/show/NCT00596297 Completed University of Sao Paulo 2008-09-30
NCT00563121 VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V https://ClinicalTrials.gov/show/NCT00563121 Completed Asociación para Evitar la Ceguera en México NA
NCT00548197 Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment https://ClinicalTrials.gov/show/NCT00548197 Completed Iran University of Medical Sciences 2008-02-29
NCT00545870 Bevacizumab Versus Ranibizumab for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00545870 Completed Medical University of Vienna 2013-03-31
NCT00542178 Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) https://ClinicalTrials.gov/show/NCT00542178 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-12-31
NCT00511875 Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00511875 Completed Milton S. Hershey Medical Center 2012-05-31
NCT00500396 Vascular Endothelial Growth Factor in Stage V ROP https://ClinicalTrials.gov/show/NCT00500396 Completed Asociación para Evitar la Ceguera en México NA
NCT00500097 Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training https://ClinicalTrials.gov/show/NCT00500097 Completed Ministry of Health, Thailand NA
NCT00481546 Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations https://ClinicalTrials.gov/show/NCT00481546 Active, not recruiting University of Pennsylvania 2026-06-30
NCT00446381 Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) https://ClinicalTrials.gov/show/NCT00446381 Completed Lawson Health Research Institute 2008-09-30
NCT00445003 Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00445003 Completed Jaeb Center for Health Research 2009-10-31
NCT00444600 Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00444600 Completed Jaeb Center for Health Research 2009-12-31
NCT00443521 Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00443521 Completed University of Sao Paulo NA
NCT00437593 UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue https://ClinicalTrials.gov/show/NCT00437593 Completed The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 2008-05-31
NCT00799695 Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population https://ClinicalTrials.gov/show/NCT00799695 Completed Henry Ford Health System 2008-05-31
NCT00423059 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00423059 Completed Yonsei University NA
NCT00422721 Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy https://ClinicalTrials.gov/show/NCT00422721 Completed Nantes University Hospital NA
NCT00411333 Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00411333 Completed National Eye Institute (NEI) 2009-07-31
NCT00406991 Retinal Blood Flow and Microthrombi in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT00406991 Completed Massachusetts Eye and Ear Infirmary NA
NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00401115 Completed Santen Inc. 2008-06-30
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00387582 Completed Rocky Mountain Retina Consultants 2009-02-28
NCT00385333 Metabolic Mapping to Measure Retinal Metabolism https://ClinicalTrials.gov/show/NCT00385333 Completed National Institutes of Health Clinical Center (CC) 2008-06-01
NCT00370851 Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT00370851 Completed Shahid Beheshti University of Medical Sciences 2008-02-29
NCT00355680 Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00355680 Completed Aurolab 2006-07-31
NCT00337298 The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT00337298 Completed University of Aarhus 2009-02-28
NCT00252733 Diabetic Retinopathy Candesartan Trials https://ClinicalTrials.gov/show/NCT00252733 Completed AstraZeneca 2008-04-30
NCT00252720 DIabetic Retinopathy Candesartan Trials. https://ClinicalTrials.gov/show/NCT00252720 Completed AstraZeneca 2008-02-29
NCT00252694 DIabetic Retinopathy Candesartan Trials https://ClinicalTrials.gov/show/NCT00252694 Completed AstraZeneca 2008-02-29
NCT00231023 Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00231023 Completed National Institutes of Health Clinical Center (CC) NA
NCT00198471 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment https://ClinicalTrials.gov/show/NCT00198471 Completed Bausch & Lomb Incorporated 2006-11-30
NCT00174824 Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT00174824 Completed Sanofi 2007-04-30
NCT00155454 Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00155454 Completed National Taiwan University Hospital 2012-12-31
NCT00131144 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00131144 Completed Novartis 2005-12-31
NCT00130845 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00130845 Completed Novartis 2005-12-31
NCT00119535 Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes https://ClinicalTrials.gov/show/NCT00119535 Completed VA Office of Research and Development NA
NCT00101764 Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders https://ClinicalTrials.gov/show/NCT00101764 Completed National Institutes of Health Clinical Center (CC) NA
NCT00035906 Research Study in Patients With Persistent Macular Edema https://ClinicalTrials.gov/show/NCT00035906 Completed Allergan 2004-08-31
NCT00295828 A Pilot Study for the Treatment of Iris Neovascularization With Macugen https://ClinicalTrials.gov/show/NCT00295828 Completed Hermann Eye Center 2008-09-30
NCT00001865 HAT in Eye Complications of Behcet’s Disease https://ClinicalTrials.gov/show/NCT00001865 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000160 Diabetic Retinopathy Study (DRS) https://ClinicalTrials.gov/show/NCT00000160 Completed National Eye Institute (NEI) NA
NCT00000159 Sorbinil Retinopathy Trial (SRT) https://ClinicalTrials.gov/show/NCT00000159 Completed National Eye Institute (NEI) NA
NCT00000156 The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP) https://ClinicalTrials.gov/show/NCT00000156 Completed National Eye Institute (NEI) NA
NCT00000154 Diabetic Retinopathy Vitrectomy Study (DRVS) https://ClinicalTrials.gov/show/NCT00000154 Completed National Eye Institute (NEI) NA
NCT00000151 Early Treatment Diabetic Retinopathy Study (ETDRS) https://ClinicalTrials.gov/show/NCT00000151 Completed National Eye Institute (NEI) NA
NCT00000133 Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT00000133 Completed National Eye Institute (NEI) NA
NCT00000131 Central Vein Occlusion Study (CVOS) https://ClinicalTrials.gov/show/NCT00000131 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03713268 Intraoperative OCT Guidance of Intraocular Surgery II https://ClinicalTrials.gov/show/NCT03713268 Recruiting Duke University 2023-05-31
NCT03396042 Natural History Study of CEP290-Related Retinal Degeneration https://ClinicalTrials.gov/show/NCT03396042 Recruiting Allergan 2020-12-31
NCT03865134 Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT03865134 Completed Istanbul Medipol University Hospital 2019-03-25
NCT03823092 Polarization Perception in Health and Disease. Testing a New Sight Test https://ClinicalTrials.gov/show/NCT03823092 Recruiting South Warwickshire NHS Foundation Trust 2019-04-30
NCT03821753 The Effect of the Glycemic Variability on Macular Retinal Microcirculation and Cognitive Functions in Patient With Type 1 Diabetes https://ClinicalTrials.gov/show/NCT03821753 Recruiting Assistance Publique - Hôpitaux de Paris 2020-05-01
NCT03334513 Refractive Error and Biometry in Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT03334513 Completed Changhua Christian Hospital 2014-04-01
NCT03314467 Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes. https://ClinicalTrials.gov/show/NCT03314467 Recruiting Centre Hospitalier Universitaire Saint Pierre 2020-06-30
NCT03112005 Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool https://ClinicalTrials.gov/show/NCT03112005 Completed Eyenuk, Inc. 2018-05-31
NCT03076697 Smartphone Screening for Eye Diseases https://ClinicalTrials.gov/show/NCT03076697 Enrolling by invitation University of Michigan 2023-06-30
NCT03068702 New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA) https://ClinicalTrials.gov/show/NCT03068702 Completed Dr. S.S. Michel Clinic 2017-01-12
NCT02963441 A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02963441 Completed IDx LLC 2017-11-30
NCT02946879 Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65) https://ClinicalTrials.gov/show/NCT02946879 Recruiting MeiraGTx UK II Ltd 2023-04-30
NCT02927561 Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening https://ClinicalTrials.gov/show/NCT02927561 Completed Retina Clinic, Sao Paulo, Brazil 2016-06-30
NCT02814929 Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey https://ClinicalTrials.gov/show/NCT02814929 Completed Etlik Zubeyde Hanım Women’s Health Care, Training and Research Hospital 2017-08-01
NCT02811536 Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A) https://ClinicalTrials.gov/show/NCT02811536 Recruiting University Hospital Inselspital, Berne 2020-12-31
NCT02691312 Pediatric Type 1 Diabetes and Retinopathy https://ClinicalTrials.gov/show/NCT02691312 Completed University of Florida 2018-01-20
NCT02625649 Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT02625649 Completed University of Aarhus 2016-12-31
NCT02575430 Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT https://ClinicalTrials.gov/show/NCT02575430 Completed QLT Inc. 2016-03-31
NCT02887157 Analyzing Retinal Microanatomy in ROP https://ClinicalTrials.gov/show/NCT02887157 Recruiting Duke University 2021-03-31
NCT03403699 Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03403699 Recruiting University of Alabama at Birmingham 2021-01-31
NCT03403686 Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR) https://ClinicalTrials.gov/show/NCT03403686 Recruiting University of Alabama at Birmingham 2021-12-31
NCT03403283 Dyslipidemia and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03403283 Recruiting University of Alabama at Birmingham 2021-12-31
NCT01145196 Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene https://ClinicalTrials.gov/show/NCT01145196 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01496625 National Eye Institute Biorepository for Retinal Diseases https://ClinicalTrials.gov/show/NCT01496625 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02464800 Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02464800 Completed Kyorin University 2014-03-31
NCT02423213 DISCOVER Study: Microscope-integrated Intraoperative OCT Study https://ClinicalTrials.gov/show/NCT02423213 Recruiting The Cleveland Clinic 2022-01-31
NCT02386839 Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) https://ClinicalTrials.gov/show/NCT02386839 Active, not recruiting Shire 2021-08-13
NCT02330042 OCT Biomarkers for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02330042 Recruiting Oregon Health and Science University 2021-12-31
NCT02232503 Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia https://ClinicalTrials.gov/show/NCT02232503 Completed Novartis 2015-11-30
NCT02196584 Clinical Evaluation of the RAVI-Guide https://ClinicalTrials.gov/show/NCT02196584 Completed Medical College of Wisconsin 2015-09-30
NCT02162953 Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. https://ClinicalTrials.gov/show/NCT02162953 Active, not recruiting Mayo Clinic 2021-12-31
NCT02157727 Cost-effectiveness of Tele-expertise for Premature Infants for Retinopathy https://ClinicalTrials.gov/show/NCT02157727 Completed Assistance Publique - Hôpitaux de Paris 2015-06-30
NCT02026843 Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02026843 Recruiting Kyungpook National University Hospital 2020-04-30
NCT02077127 Monocyte Chemoattractant Protein-1 2518A/G Polymorphism https://ClinicalTrials.gov/show/NCT02077127 Completed Harbin Medical University 2013-02-28
NCT01307072 Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01307072 Completed Kyorin University 2009-08-31
NCT02050880 OCT Agreement and Crossed Precision Study https://ClinicalTrials.gov/show/NCT02050880 Completed Nidek Co. LTD. 2014-06-30
NCT02045823 OCT Agreement and Precision Study https://ClinicalTrials.gov/show/NCT02045823 Completed Topcon Medical Systems, Inc. 2014-04-30
NCT01946997 Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT01946997 Completed Johns Hopkins University 2009-11-30
NCT01928550 Diabetes PRP and OCT https://ClinicalTrials.gov/show/NCT01928550 Completed Oregon Health and Science University 2016-05-25
NCT01878032 Color Vision as a Measure for Inherited Retinal Diseases https://ClinicalTrials.gov/show/NCT01878032 Completed National Institutes of Health Clinical Center (CC) 2017-04-14
NCT01871207 Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy https://ClinicalTrials.gov/show/NCT01871207 Completed Università degli Studi di Brescia 2012-01-31
NCT01815567 DETECT and Retinal Outcomes in Hypertension https://ClinicalTrials.gov/show/NCT01815567 Recruiting Emory University 2020-01-31
NCT01792154 Measuring Corneal Cells With Specular Microscopy https://ClinicalTrials.gov/show/NCT01792154 Completed Retina Institute of Hawaii 2012-11-30
NCT01790958 Microcurrent Stimulation to Treat Macular Degeneration https://ClinicalTrials.gov/show/NCT01790958 Completed Retina Institute of Hawaii 2012-12-31
NCT01760746 Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis https://ClinicalTrials.gov/show/NCT01760746 Completed University of British Columbia 2013-10-31
NCT01736293 Natural History of Eye Diseases Related to ABCA4 Mutations https://ClinicalTrials.gov/show/NCT01736293 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT01728883 Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study https://ClinicalTrials.gov/show/NCT01728883 Completed Vital Art and Science Incorporated 2016-04-30
NCT01692938 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO https://ClinicalTrials.gov/show/NCT01692938 Completed Optos, PLC 2012-11-30
NCT04125043 Pediatric Red Reflex Study https://ClinicalTrials.gov/show/NCT04125043 Recruiting Children’s National Research Institute 2020-11-01
NCT01625598 Computer Detection of Diabetic Retinopathy Compared to Clinical Examination https://ClinicalTrials.gov/show/NCT01625598 Completed IDx LLC 2014-04-30
NCT01622816 Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart https://ClinicalTrials.gov/show/NCT01622816 Completed Wills Eye 2013-12-31
NCT01614327 Computer-based Screening for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01614327 Completed VisionQuest Biomedical LLC 2015-02-24
NCT01607190 Biomarkers of Diabetic Retinopathy Progression https://ClinicalTrials.gov/show/NCT01607190 Completed Association for Innovation and Biomedical Research on Light and Image 2016-04-30
NCT01546766 Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device) https://ClinicalTrials.gov/show/NCT01546766 Completed University of California, Los Angeles 2015-08-31
NCT01478763 Vitrous Analysis in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01478763 Completed St. Erik Eye Hospital 2014-09-30
NCT01440660 Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) https://ClinicalTrials.gov/show/NCT01440660 Completed Association for Innovation and Biomedical Research on Light and Image 2014-09-30
NCT01415037 Annular Array Ultrasound in Ophthalmology https://ClinicalTrials.gov/show/NCT01415037 Completed Columbia University 2016-12-31
NCT01412905 Telemedicine Retinal Screening Utilizing a Mobile Medical Unit https://ClinicalTrials.gov/show/NCT01412905 Completed Scripps Whittier Diabetes Institute 2008-12-31
NCT01384487 Nidek RS3000 Comparative Study https://ClinicalTrials.gov/show/NCT01384487 Completed Nidek Co. LTD. 2011-11-30
NCT01363960 Retinopathy of Prematurity:Summary of a Decade https://ClinicalTrials.gov/show/NCT01363960 Completed Saglik Bilimleri Universitesi Gulhane Tip Fakultesi 2010-12-31
NCT04420156 Clinical and Genetic Analysis of ROP https://ClinicalTrials.gov/show/NCT04420156 Recruiting Oregon Health and Science University 2024-05-31
NCT04378972 Anti-inflammatory Effect of Curcumin, Homotaurine, Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04378972 Completed University of Molise 2019-11-16
NCT03347799 WINROP Algorithm Validation for Retinopathy Screening in a Cohort of Premature Infants https://ClinicalTrials.gov/show/NCT03347799 Completed Central Hospital, Nancy, France 2016-07-01
NCT04289064 Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on Diagnosis https://ClinicalTrials.gov/show/NCT04289064 Active, not recruiting Sun Yat-sen University 2020-07-01
NCT04092127 Pain and RetCam (DOLICAM) https://ClinicalTrials.gov/show/NCT04092127 Recruiting University Hospital, Grenoble 2020-11-12
NCT04018326 Loss to Follow-up in PDR Patients https://ClinicalTrials.gov/show/NCT04018326 Completed Assiut University 2018-06-01
NCT04010110 Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics https://ClinicalTrials.gov/show/NCT04010110 Completed The Eye Center and The Eye Foundation for Research in Ophthalmology 2019-06-01
NCT03922932 WF and PR OCTA in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03922932 Recruiting Oregon Health and Science University 2023-12-31
NCT03912961 The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study https://ClinicalTrials.gov/show/NCT03912961 Completed Retina Global 2019-04-14
NCT03911323 Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening https://ClinicalTrials.gov/show/NCT03911323 Recruiting Shenzhen Second People’s Hospital 2020-10-01
NCT03903042 Comparison of Aurora Fundus Camera With Traditional Camera in Diabetic Retinopathy With Visual Artificial Intelligence https://ClinicalTrials.gov/show/NCT03903042 Enrolling by invitation Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2019-05-31
NCT03899623 Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application https://ClinicalTrials.gov/show/NCT03899623 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2019-12-31
NCT03694145 Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images https://ClinicalTrials.gov/show/NCT03694145 Recruiting Charles Drew University of Medicine and Science 2020-09-30
NCT03613948 Study on the Effects of Mutations Under Inherited Retinal Disease in Korean https://ClinicalTrials.gov/show/NCT03613948 Recruiting Gangnam Severance Hospital 2020-12-31
NCT03609996 Retrospective Review of Proliferative Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT03609996 Active, not recruiting Elman Retina Group 2018-12-01
NCT03602989 A Multi-center Study on the Artificial Intelligence Enabled Diabetic Retinopathy Screening Based on Fundus Images https://ClinicalTrials.gov/show/NCT03602989 Active, not recruiting Shenzhen SiBright Co., Ltd. 2018-11-30
NCT03586193 Pars Plana Vitrectomy Alone in the Treatment of Macular Schisis in High Myopic Eyes https://ClinicalTrials.gov/show/NCT03586193 Recruiting Aier School of Ophthalmology, Central South University 2018-12-31
NCT03572699 Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study https://ClinicalTrials.gov/show/NCT03572699 Recruiting Medios Technologies Pte. Ltd 2018-10-31
NCT03571659 Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03571659 Completed L.V. Prasad Eye Institute 2014-12-22
NCT03528720 Evaluation System and Clinical Application for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03528720 Completed Guangdong Provincial People’s Hospital 2018-04-30
NCT03522311 Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function https://ClinicalTrials.gov/show/NCT03522311 Completed Kyorin University 2016-03-31
NCT03448640 Efficacy of Mydriatic Drops in Premature Infants https://ClinicalTrials.gov/show/NCT03448640 Completed Bulent Ecevit University 2017-10-15
NCT03438903 Comparison of Repeatability Between SS and SD-OCT for Measuring Retinal Thickness in Various Retinal Diseases https://ClinicalTrials.gov/show/NCT03438903 Completed Hanyang University 2018-01-31
NCT03437018 MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE https://ClinicalTrials.gov/show/NCT03437018 Recruiting Centre Hospitalier Sud Francilien 2021-01-13
NCT01264276 Telemedicine Approaches to Evaluating Acute-phase ROP https://ClinicalTrials.gov/show/NCT01264276 Completed Children’s Hospital of Philadelphia 2013-10-31
NCT01228981 Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01228981 Completed Association for Innovation and Biomedical Research on Light and Image 2011-06-30
NCT01145599 Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures https://ClinicalTrials.gov/show/NCT01145599 Completed European Vision Institute Clinical Research Network 2013-10-31
NCT01131650 Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil https://ClinicalTrials.gov/show/NCT01131650 Completed Hospital do Olho Rio Preto 2009-11-30
NCT01128062 Canthaxanthin Retinopathy: A Long-term Observation https://ClinicalTrials.gov/show/NCT01128062 Completed University of Cologne 2009-12-31
NCT00906659 Visual Function, Center Point Thickness and Macular Volume After Photocoagulation https://ClinicalTrials.gov/show/NCT00906659 Completed Hospital Juarez de Mexico 2007-12-31
NCT00895869 Pain in Neonates During Screening for Retinopathy of Prematurity Using Two Methods https://ClinicalTrials.gov/show/NCT00895869 Completed NHS Lothian 2008-01-31
NCT00886392 Diabetic Macular Edema Severity at Diagnosis https://ClinicalTrials.gov/show/NCT00886392 Completed Hospital Juarez de Mexico 2007-12-31
NCT00845624 Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants https://ClinicalTrials.gov/show/NCT00845624 Completed University of Virginia 2009-06-30
NCT00840541 Phenotyping Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00840541 Completed Association for Innovation and Biomedical Research on Light and Image 2010-01-31
NCT00839150 Retinal Function in Diabetic Patients Without Retinopathy https://ClinicalTrials.gov/show/NCT00839150 Completed Assistance Publique - Hôpitaux de Paris 2007-01-31
NCT00828425 Management of Diabetes Mellitus Patients With Retinopathy https://ClinicalTrials.gov/show/NCT00828425 Completed AstraZeneca NA
NCT03894020 To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) https://ClinicalTrials.gov/show/NCT03894020 Recruiting Gyroscope Therapeutics 2023-01-08
NCT01780155 Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01780155 Recruiting National Institutes of Health Clinical Center (CC) 2022-09-26
NCT01559571 Registry for Severe ROP and Treatment on Visual Outcomes https://ClinicalTrials.gov/show/NCT01559571 Completed Mednax Center for Research, Education, Quality and Safety 2020-05-15
NCT01432847 Cell Collection to Study Eye Diseases https://ClinicalTrials.gov/show/NCT01432847 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03078231 Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool https://ClinicalTrials.gov/show/NCT03078231 Completed Eyenuk, Inc. 2017-04-24
NCT02875704 Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02875704 Recruiting Johns Hopkins University 2021-05-31
NCT02662010 The Relationship Between Advanced Glycation Endproducts and Diabetes https://ClinicalTrials.gov/show/NCT02662010 Recruiting University of Colorado, Denver 2021-01-31
NCT02637245 Imaging Parameters and DME Treatment Response https://ClinicalTrials.gov/show/NCT02637245 Recruiting Duke University 2020-05-31
NCT02822612 The EASE Study - Human Factor and Usability Testing of a Binocular OCT System https://ClinicalTrials.gov/show/NCT02822612 Completed University College, London 2016-10-31
NCT04030611 The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study https://ClinicalTrials.gov/show/NCT04030611 Recruiting China Medical University Hospital 2019-09-01
NCT00792259 Topcon 3D OCT-1000 Optical Coherence Tomography System https://ClinicalTrials.gov/show/NCT00792259 Completed Topcon Medical Systems, Inc. 2008-11-30
NCT00763802 Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 https://ClinicalTrials.gov/show/NCT00763802 Completed Association for Innovation and Biomedical Research on Light and Image 2010-09-30
NCT00737074 Macular Hole in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00737074 Completed National Taiwan University Hospital 2007-11-30
NCT00728598 Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis https://ClinicalTrials.gov/show/NCT00728598 Completed National Taiwan University Hospital 1998-12-31
NCT00720317 Diabetic Retinopathy and Sickle Trait https://ClinicalTrials.gov/show/NCT00720317 Completed Medical University of South Carolina 2010-07-31
NCT00712842 Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy https://ClinicalTrials.gov/show/NCT00712842 Completed Medical University of Vienna 2011-09-30
NCT00709319 Evaluation of Vitrectomy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00709319 Completed Jaeb Center for Health Research 2008-08-31
NCT00647439 Genetics and Markers of Degenerative and Inflammatory Eye Diseases https://ClinicalTrials.gov/show/NCT00647439 Completed National Institutes of Health Clinical Center (CC) NA
NCT00596505 Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00596505 Completed National Taiwan University Hospital 2007-12-31
NCT00279669 Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT00279669 Completed Weill Medical College of Cornell University 2010-04-30
NCT00259701 Microvascular Reactivity. https://ClinicalTrials.gov/show/NCT00259701 Completed Yale University NA
NCT00106756 Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy https://ClinicalTrials.gov/show/NCT00106756 Completed National Institutes of Health Clinical Center (CC) 2006-11-01
NCT00069199 Optical Coherence Tomography Comparative Study https://ClinicalTrials.gov/show/NCT00069199 Completed National Institutes of Health Clinical Center (CC) NA
NCT00797524 Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT00797524 Completed Association for Innovation and Biomedical Research on Light and Image 2010-10-31
NCT00001668 Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors https://ClinicalTrials.gov/show/NCT00001668 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001612 Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS) https://ClinicalTrials.gov/show/NCT00001612 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001395 Long Term Follow-Up of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00001395 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001346 Diabetic Retinopathy and Visual Function Study https://ClinicalTrials.gov/show/NCT00001346 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005784 Evaluation and Treatment of Patients With Retinal Disease https://ClinicalTrials.gov/show/NCT00005784 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005761 Blood Factors and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00005761 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001733 Screening for Studies on Retinovascular Diseases https://ClinicalTrials.gov/show/NCT00001733 Completed National Institutes of Health Clinical Center (CC) NA
NCT00006188 Evaluation and Treatment of Patients With Inflammatory Eye Diseases https://ClinicalTrials.gov/show/NCT00006188 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03010397 Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes https://ClinicalTrials.gov/show/NCT03010397 Completed Association for Innovation and Biomedical Research on Light and Image 2017-01-11
NCT02484989 UK Surveillance of Treated Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT02484989 Completed Moorfields Eye Hospital NHS Foundation Trust 2015-07-31
NCT02435940 Inherited Retinal Degenerative Disease Registry https://ClinicalTrials.gov/show/NCT02435940 Recruiting Foundation Fighting Blindness 2037-06-30
NCT02119689 Vascular Reparative Mechanism in Diabetes https://ClinicalTrials.gov/show/NCT02119689 Active, not recruiting University of Alabama at Birmingham 2019-10-09
NCT01824862 Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01824862 Completed Hospital Juarez de Mexico 2013-06-30
NCT01785667 Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark https://ClinicalTrials.gov/show/NCT01785667 Completed Odense University Hospital 2011-11-30
NCT04240652 The Diabetic Retinopathy Screening, Prevention and Control Program https://ClinicalTrials.gov/show/NCT04240652 Recruiting Shanghai Jiao Tong University School of Medicine 2038-06-05
NCT03571217 Shanghai Beixinjing Diabetic Eyes Study https://ClinicalTrials.gov/show/NCT03571217 Recruiting Shanghai Eye Disease Prevention and Treatment Center 2024-12-31
NCT03542734 Cognitive Impairment, Retinopathy, and Cerebrovascular Lesions in the Elderly https://ClinicalTrials.gov/show/NCT03542734 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2027-05-30
NCT03476967 Effect of Laser Treatment for Diabetic Retinopathy on the Optic Disc Topography https://ClinicalTrials.gov/show/NCT03476967 Completed University of Sao Paulo General Hospital 2017-01-31